Announcing a new publication for BIO integration iris. In this report the authors Phei Er Saw and Sangyong Jon from Sun Yat-Sen University, Guangzhou, China and the Korea Institute of Advanced Science and Technology, Daejeon, Korea, discuss how nanoparticles’ entry equipment to tumors future determination of nanomedicine pathway. development.
Improved reconstitution and retention (EPR) allows nanoparticles to passively accumulate at tumor sites through gaps between endothelial cells (inter-endothelial gaps) in tumor-associated blood vessels that have structural integrity or -usual with pores ranging in size from submicron to micron.
The authors review future nanomedicine development guidelines, focusing on nanoparticle entry equipment into tumors rather than clinical transformation itself. Improved nanoparticle design to achieve effective clinical transformation can be achieved with an in-depth understanding of nanoparticle induction or function.